Boston Scientific's revenue grew 13% to $12.2 billion over the last twelve months, compared to $10.7 billion in 2019, primarily led by higher sales for its peripheral interventions, endoscopy, and women's health products.
Boston Scientific's revenue grew 13% to $12.2 billion over the last twelve months, compared to $10.7 billion in 2019, primarily led by higher sales for its peripheral interventions, endoscopy, and women's health products.
Share this Article
Recommended